To determine whether siglec-4 could affect chimeric antigen receptor T (CAR-T) cell activity, we created CAR-T cells against the cancer-associated cell surface protein Tumor Endothelial Marker 8 (TEM8)/Anthrax toxin receptor 1 (ANTXR1) (fig. The gene discussed is ANTXR1; the disease is cancer.